Argenx Nv Adr Stock Performance
| ARGX Stock | USD 596.74 4.92 0.83% |
On a scale of 0 to 100, Argenx NV holds a performance score of 9. The firm shows a Beta (market volatility) of -0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Argenx NV are expected to decrease at a much lower rate. During the bear market, Argenx NV is likely to outperform the market. Please check Argenx NV's downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether Argenx NV's price patterns will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in argenx NV ADR are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady technical and fundamental indicators, Argenx NV showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.45 | Five Day Return 5.76 | Year To Date Return 58.89 | Ten Year Return 2.5 K | All Time Return 2.5 K |
1 | Deep Track Capital, LPs Strategic Acquisition in Reneo Pharmaceuticals Inc | 10/24/2024 |
2 | Argenx SE reports Q3 results | 10/31/2024 |
3 | Is Argenx Outperforming Other Medical Stocks This Year | 11/05/2024 |
4 | argenx stock boosted by Wolfe, citing dominance in MG and profitability ahead | 11/12/2024 |
5 | Artisan Partners Limited Partnership Adjusts Stake in RxSight Inc | 11/13/2024 |
6 | Paradigm Biocapital Advisors LP Increases Stake in Tarsus Pharmaceuticals Inc | 11/15/2024 |
7 | Is argenx SE the Best Immunotherapy Stock to Buy Now | 11/18/2024 |
8 | Can Argenx stock sustain its autoimmune category dominance Oppenheimer weighs in | 11/21/2024 |
| Begin Period Cash Flow | 800.7 M |
Argenx |
Argenx NV Relative Risk vs. Return Landscape
If you would invest 51,746 in argenx NV ADR on August 24, 2024 and sell it today you would earn a total of 7,928 from holding argenx NV ADR or generate 15.32% return on investment over 90 days. argenx NV ADR is currently generating 0.2424% in daily expected returns and assumes 1.9892% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Argenx, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Argenx NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Argenx NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as argenx NV ADR, and traders can use it to determine the average amount a Argenx NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1218
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ARGX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.99 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Argenx NV is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Argenx NV by adding it to a well-diversified portfolio.
Argenx NV Fundamentals Growth
Argenx Stock prices reflect investors' perceptions of the future prospects and financial health of Argenx NV, and Argenx NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Argenx Stock performance.
| Return On Equity | -0.0574 | ||||
| Return On Asset | -0.0551 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 31.84 B | ||||
| Shares Outstanding | 59.8 M | ||||
| Price To Earning | 5.54 X | ||||
| Price To Book | 8.37 X | ||||
| Price To Sales | 18.70 X | ||||
| Revenue | 1.23 B | ||||
| Gross Profit | (251.79 M) | ||||
| EBITDA | (216.02 M) | ||||
| Net Income | (425.05 M) | ||||
| Cash And Equivalents | 2.6 B | ||||
| Cash Per Share | 47.17 X | ||||
| Total Debt | 20 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 11.07 X | ||||
| Book Value Per Share | 71.28 X | ||||
| Cash Flow From Operations | (420.33 M) | ||||
| Earnings Per Share | (0.78) X | ||||
| Market Capitalization | 35.68 B | ||||
| Total Asset | 4.54 B | ||||
| Retained Earnings | (2.4 B) | ||||
| Working Capital | 3.7 B | ||||
| Current Asset | 78.94 M | ||||
| Current Liabilities | 30.84 M | ||||
About Argenx NV Performance
Evaluating Argenx NV's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Argenx NV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Argenx NV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 961.94 | 1,010 | |
| Return On Tangible Assets | (0.07) | (0.07) | |
| Return On Capital Employed | (0.10) | (0.11) | |
| Return On Assets | (0.06) | (0.07) | |
| Return On Equity | (0.07) | (0.08) |
Things to note about argenx NV ADR performance evaluation
Checking the ongoing alerts about Argenx NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for argenx NV ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 1.23 B. Net Loss for the year was (425.05 M) with loss before overhead, payroll, taxes, and interest of (251.79 M). | |
| argenx NV ADR currently holds about 2.6 B in cash with (420.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 47.17. | |
| Roughly 60.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investing.com: Can Argenx stock sustain its autoimmune category dominance Oppenheimer weighs in |
- Analyzing Argenx NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Argenx NV's stock is overvalued or undervalued compared to its peers.
- Examining Argenx NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Argenx NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Argenx NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Argenx NV's stock. These opinions can provide insight into Argenx NV's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Argenx Stock Analysis
When running Argenx NV's price analysis, check to measure Argenx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argenx NV is operating at the current time. Most of Argenx NV's value examination focuses on studying past and present price action to predict the probability of Argenx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argenx NV's price. Additionally, you may evaluate how the addition of Argenx NV to your portfolios can decrease your overall portfolio volatility.